X4 Pharmaceuticals, Inc. (XFOR)
4.035
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 15:28
X4 Pharmaceuticals Net Income (Annual) : -79.20M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -79.20M |
| December 31, 2024 | -37.45M |
| December 31, 2023 | -101.17M |
| December 31, 2022 | -93.87M |
| December 31, 2021 | -88.70M |
| December 31, 2020 | -62.13M |
| Date | Value |
|---|---|
| December 31, 2019 | -52.81M |
| December 31, 2018 | -33.28M |
| December 31, 2017 | -33.88M |
| December 31, 2016 | -22.98M |
| December 31, 2015 | -13.22M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | -713.41M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |
| Sangamo Therapeutics, Inc. | -122.93M |
| Anixa Biosciences, Inc. | -11.03M |